Mithra logo.jpg
Mithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in China
04 déc. 2023 01h00 HE | Mithra Pharmaceuticals
          Mithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in China Mithra signs binding Head of Terms for a twenty-year partnership with Gedeon-Richter...
Mithra logo.jpg
Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States
30 nov. 2023 01h00 HE | Mithra Pharmaceuticals
Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States DONESTA® for the treatment of vasomotor symptoms of menopause, is expected to target...
Mithra logo.jpg
Mithra to hold five presentations on key role of estrogens in women’s health, including Estetrol (E4), at the ESG Congress in Amsterdam
28 nov. 2023 11h45 HE | Mithra Pharmaceuticals
Mithra to hold five presentations on key role of estrogens in women’s health, including Estetrol (E4), at the ESG Congress in Amsterdam Five abstracts on the positive effect of E4 accepted for oral...
Mithra logo.jpg
Mithra’s NEXTSTELLIS® granted additional patent in the United States
07 nov. 2023 01h00 HE | Mithra Pharmaceuticals
                                                          Mithra’s NEXTSTELLIS® granted additional patent in the United States New patent extends protection for NEXTSTELLIS® (ESTELLE®) until...
Mithra logo.jpg
Mithra releases invitation to its extraordinary securities holders’ meeting
06 nov. 2023 12h52 HE | Mithra Pharmaceuticals
            Mithra releases invitation to its extraordinary securities holders’ meeting Liege, Belgium, 06 November 2023 – 17:45 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to...
Mithra logo.jpg
Mithra and Searchlight Pharma sign DONESTA® licensing agreement for Canada
26 oct. 2023 01h00 HE | Mithra Pharmaceuticals
                                             Mithra and Searchlight Pharma sign DONESTA® licensing agreement for Canada Mithra to receive EUR 1.5 million milestone payout as a result of the signing...
Mithra logo.jpg
Mithra to receive EUR 2.5 million milestone payment from Fuji Pharma under ESTELLE® licensing agreement
23 oct. 2023 01h00 HE | Mithra Pharmaceuticals
        Mithra to receive EUR 2.5 million milestone payment from Fuji Pharma under ESTELLE® licensing agreement Relates to the submission of a marketing approval application in JapanMarks strong...
Mithra logo.jpg
Mithra’s Board of Directors to propose the removal of its request for change of the remuneration policy at the Special General Meeting
17 oct. 2023 01h00 HE | Mithra Pharmaceuticals
Mithra’s Board of Directors to propose the removal of its request for change of the remuneration policy at the Special General Meeting Liege, Belgium, 17 October 2023 – 7:00 CEST – Mithra...
Mithra logo.jpg
Shareholder Letter
11 oct. 2023 01h15 HE | Mithra Pharmaceuticals
Dear Shareholders,  We write to you today with a deep sense of responsibility and transparency, driven by our commitment to the principles of sound corporate governance and the long-term success of...
Mithra logo.jpg
Mithra announces update to the agenda of its upcoming special general shareholders’ meeting
11 oct. 2023 01h00 HE | Mithra Pharmaceuticals
             Liege, Belgium, 11 October 2023 – 7:00 CEST – Mithra (Euronext Brussels: MITRA) (the "Company"), a company dedicated to Women’s Health, today announces that it has received a...